The influence of APOE status on rate of cognitive decline

Fleming, R., Zeisel, J. & Bennett, K. World alzheimer report 2020: Design Dignity Dementia: dementia-related design and the built environment. London, England: Alzheimer’s Disease International; 2020. p. 1.

Jack CR, Bennett D, Blennow K, et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease. Physiol Behav. 2018;176(5):139–48. https://doi.org/10.1016/j.jalz.2018.02.018.NIA-AA.

Article  Google Scholar 

Petersen RC. Mild cognitive impairment. CONTINUUM: Lifelong Learning in Neurology, 22(2 Dementia). 2016;404–418. https://doi.org/10.1212/CON.0000000000000313.

Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dement. 2011;7(3):280–92. https://doi.org/10.1016/j.jalz.2011.03.003.

Article  Google Scholar 

Corder E, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science. 1993;261:921–3.

Article  PubMed  CAS  Google Scholar 

Heffernan AL, Chidgey C, Peng P, Masters CL, Roberts BR. The Neurobiology and Age-Related Prevalence of the ε4 Allele of Apolipoprotein E in Alzheimer’s Disease Cohorts. J Mol Neurosci. 2016;60(3):316–24. https://doi.org/10.1007/s12031-016-0804-x.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Albert M, Soldan A, Gottesman R, et al. Cognitive changes preceding clinical symptom onset of mild cognitive impairment and relationship to ApoE genotype. Curr Alzheimer Res. 2015;11(8):773–84.

Article  Google Scholar 

Liu CC, Kanekiyo T, Xu HBG. Apolipoprotein E and Alzheimer disease: risk, mechanisms, and therapy. Nat Rev Neurosci. 2013;9(2):106–18. https://doi.org/10.1038/nrneurol.2012.263.Apolipoprotein.

Article  CAS  Google Scholar 

Koutsodendris N, Nelson MR, Rao A, Huang Y. Apolipoprotein E and Alzheimer’s Disease: Findings, Hypotheses, and Potential Mechanisms. Annu Rev Pathol Mech Dis. 2021;17:73–99. https://doi.org/10.1146/annurev-pathmechdis-030421-112756.

Article  CAS  Google Scholar 

van Harten AC, Mielke MM, Swenson-dravis DM, Hagen CE. Subjective cognitive decline and risk of MCI The Mayo Clinic Study of Aging. Published online. 2018. https://doi.org/10.1212/WNL.0000000000005863.

Article  Google Scholar 

Jessen F, Amariglio RE, Buckley RF, van der Flier WM, Han Y, Molinuevo JL, Wagner M. The characterisation of subjective cognitive decline. TheLancet Neurology. 2020;19(3):271–8. https://doi.org/10.1016/S1474-4422(19)30368-0.

Article  Google Scholar 

Rabin LA, Smart CM, Amariglio RE. Subjective Cognitive Decline in Preclinical Alzheimer’s Disease. Annu Rev Clin Psychol. 2017;13:369–96. https://doi.org/10.1146/annurev-clinpsy-032816-045136.

Article  PubMed  Google Scholar 

Moreno-Grau S, Rodr O, Maule A, et al. Exploring APOE genotype effects on Alzheimer’ s disease risk and amyloid b burden in individuals with subjective cognitive decline : The FundacioACE Healthy Brain Initiative ( FACEHBI ) study baseline results. Alzheimer’s Dement. 2018;14:634–43. https://doi.org/10.1016/j.jalz.2017.10.005.

Article  Google Scholar 

Ali JI, Smart CM, Gawryluk JR. Subjective Cognitive Decline and APOE e4: A Systematic Review. J Alzheimer’s Dis Published online. 2018. https://doi.org/10.3233/JAD-180248.

Article  Google Scholar 

Barnes LL, Shah RC, Aggarwal NT, Bennett DA, Schneider JA. The Minority Aging Research Study: ongoing efforts to obtain brain donation in African Americanswithout dementia. Curr Alzheimer Res. 2012;9(6):734–45. https://doi.org/10.2174/156720512801322627.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Schneider JA, Aggarwal NT, Barnes L, Boyle P, Bennett DA. The neuropathology of older persons with and without dementia from community versus clinic cohorts. J Alzheimer’s Dis. 2009;18(3):691–701. https://doi.org/10.3233/JAD-2009-1227.

Article  Google Scholar 

Bennett DA, Buchman AS, Boylea PA, Barnesa LL, Wilson RS, Schneidera JA. Religious Orders Study and Rush Memory and Aging Project. J Alzheimer’s Dis. 2018;64(Suppl 1):S161–89. https://doi.org/10.3233/JAD-179939.Religious.

Article  Google Scholar 

McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dement. 2011;7(3):263–9. https://doi.org/10.1016/j.jalz.2011.03.005.

Article  Google Scholar 

Arvanitakis Z, Capuano AW, Bennett DA, Barnes LL. Body Mass Index and Decline in Cognitive Function in Older Black and White Persons. J Gerontol A Biol Sci Med Sci. 2018;73(2):198–203. https://doi.org/10.1093/gerona/glx152.

Article  PubMed  Google Scholar 

Lamar M, Wilson RS, Yu L, Stewart CC, Bennett DA, Boyle PA. Associations of decision making abilities with blood pressure values in older adults. J Hypertens. 2020;38(1):59–64. https://doi.org/10.1097/HJH.0000000000002220.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal statistical society: series B (Methodological). 1995;57(1):289-300. https://doi.org/10.1111/j.2517-6161.1995.tb02031.x.

Morrison C, Oliver M. Subjective Cognitive Decline Is Associated With Lower Baseline Cognition and Increased Rate of Cognitive Decline. Journals Gerontol Ser B: Published online; 2022.

Google Scholar 

Boyle PA, Wilson RS, Aggarwal NT, Tang Y, Bennett DA. Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive decline. Neurology. 2006;67(3):441–5.

Article  PubMed  CAS  Google Scholar 

Bretsky P, Guralnik JM, Launer L, Albert M, Seeman TE. The role of APOE-ε4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging. Neurology. 2003;60(7):1077–81.

Article  PubMed  CAS  Google Scholar 

Sun Y, Yang FC, Lin CP, Han Y. Biochemical and neuroimaging studies in subjective cognitive decline: progress and perspectives. CNS Neurosci Ther. 2015;21(10):768–75. https://doi.org/10.1111/cns.12395.

Article  PubMed  PubMed Central  Google Scholar 

Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, Mukadam N. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet. 2020;396(10248):413–46. https://doi.org/10.1016/S0140-6736(20)30367-6.

Article  Google Scholar 

Berkowitz CL, Mosconi L, Rahman A, Scheyer O, Hristov H, Isaacson RS. Clinical Application of APOE in Alzheimer’s Prevention: A Precision Medicine Approach. J Prev Alzheimer’s Dis. 2018;5(4):245–52. https://doi.org/10.14283/jpad.2018.35.

Article  CAS  Google Scholar 

Smits LL, Pijnenburg YAL, van der Vlies AE, et al. Early onset APOE E4-negative Alzheimer’s disease patients show faster cognitive decline on non-memory domains. Eur Neuropsychopharmacol. 2015;25(7):1010–7. https://doi.org/10.1016/j.euroneuro.2015.03.014.

Article  PubMed  CAS  Google Scholar 

Tort-Merino A, Falgàs N, Allen IE, et al. Early-onset Alzheimer’s disease shows a distinct neuropsychological profile and more aggressive trajectories of cognitive decline than late-onset. Ann Clin Transl Neurol. 2022;9(12):1962–73. https://doi.org/10.1002/acn3.51689.

Article  PubMed  PubMed Central  Google Scholar 

Dai MH, Zheng H, Zeng LD, Zhang Y. The genes associated with early-onset Alzheimer’s disease. Oncotarget. 2018;9(19):15132–43. https://doi.org/10.18632/oncotarget.23738.

Article  PubMed  Google Scholar 

Hong YJ, Ho SH, Jeong JH, et al. Impacts of baseline biomarkers on cognitive trajectories in subjective cognitive decline: the CoSCo prospective cohort study. Alzheimer’s Res Ther. 2023;15(1):1–10. https://doi.org/10.1186/s13195-023-01273-y.

Article  CAS  Google Scholar 

Caillaud M, Maltezos S, Hudon C, Mellah S, Belleville S. Hippocampal Volume and Episodic Associative Memory Identify Memory Risk in Subjective Cognitive Decline Individuals in the CIMA-Q Cohort, Regardless of Cognitive Reserve Level and APOE4 Status. J Alzheimer’s Dis. 2023;94(3):1047–56. https://doi.org/10.3233/JAD-230131.

Article  CAS  Google Scholar 

留言 (0)

沒有登入
gif